Gordon M. Stott

1.2k total citations
11 papers, 414 citations indexed

About

Gordon M. Stott is a scholar working on Molecular Biology, Cell Biology and Oncology. According to data from OpenAlex, Gordon M. Stott has authored 11 papers receiving a total of 414 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 4 papers in Cell Biology and 3 papers in Oncology. Recurrent topics in Gordon M. Stott's work include Endoplasmic Reticulum Stress and Disease (4 papers), Ubiquitin and proteasome pathways (3 papers) and Epigenetics and DNA Methylation (2 papers). Gordon M. Stott is often cited by papers focused on Endoplasmic Reticulum Stress and Disease (4 papers), Ubiquitin and proteasome pathways (3 papers) and Epigenetics and DNA Methylation (2 papers). Gordon M. Stott collaborates with scholars based in United States and Malaysia. Gordon M. Stott's co-authors include Ulrike Langheinrich, Elisabeth Hennen, Feng Wang, Shan Li, Tsui‐Fen Chou, Andrew Flint, Kenneth M. Meyers, Jiqing Sai, William Moore and William P. Tansey and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Current Biology.

In The Last Decade

Gordon M. Stott

10 papers receiving 406 citations

Peers

Countries citing papers authored by Gordon M. Stott

Since Specialization

Citations

This map shows the geographic impact of Gordon M. Stott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gordon M. Stott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gordon M. Stott more than expected).

Fields of papers citing papers by Gordon M. Stott

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gordon M. Stott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gordon M. Stott. The network helps show where Gordon M. Stott may publish in the future.

Co-authorship network of co-authors of Gordon M. Stott

This figure shows the co-authorship network connecting the top 25 collaborators of Gordon M. Stott. A scholar is included among the top collaborators of Gordon M. Stott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gordon M. Stott. Gordon M. Stott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	Antitumor Efficacy of 1,2,4-Triazole-Based VCP/p97 Allosteric Inhibitors 2025 ·Journal of Medicinal Chemistry ·Neal Green, Matthew G. LaPorte, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Shan Li, (unknown), (unknown), Apurva K. Srivastava, Andrew Flint, William Moore, Tsui‐Fen Chou, Gordon M. Stott, M.E. Wolf, Peter Wipf, Donna M. Huryn	0
2	Expanded profiling of WD repeat domain 5 inhibitors reveals actionable strategies for the treatment of hematologic malignancies 2024 ·Proceedings of the National Academy of Sciences ·Christian T. Meyer, (unknown), Jing Wang, (unknown), Brian C. Grieb, Gregory C. Howard, Alexander J. Silver, Shelly L. Lorey, Gordon M. Stott, William Moore, Taekyu Lee, Michael R. Savona, April M. Weissmiller, Qi Liu, Vito Quaranta, Stephen W. Fesik, William P. Tansey	4
3	Mitochondrial-Encoded Complex I Impairment Induces a Targetable Dependency on Aerobic Fermentation in Hürthle Cell Carcinoma of the Thyroid 2023 ·Cancer Discovery ·Anderson R. Frank, (unknown), Spencer D. Shelton, Jiwoong Kim, Gordon M. Stott, Leonard Μ. Neckers, Yang Xie, Noelle S. Williams, Prashant Mishra, David G. McFadden	12
4	Structure-Based Discovery of Potent, Orally Bioavailable Benzoxazepinone-Based WD Repeat Domain 5 Inhibitors 2023 ·Journal of Medicinal Chemistry ·(unknown), (unknown), Jianhua Tian, Changho Han, Kenneth M. Meyers, Jiqing Sai, (unknown), (unknown), (unknown), John Sensintaffar, Bin Zhao, Kangsa Amporndanai, William Moore, Gordon M. Stott, William P. Tansey, Taekyu Lee, Stephen W. Fesik	7
5	Sulforaphane is Synergistic with CB‐5083 and Inhibits Colony Formation of CB‐5083‐Resistant HCT116 Cells 2022 ·ChemMedChem ·Feng Wang, Shan Li, William M. Rosencrans, (unknown), Gordon M. Stott, Barbara Mroczkowski, Tsui‐Fen Chou	7
6	Comparative Oncology Assessment of a Novel Inhibitor of Valosin-Containing Protein in Tumor-Bearing Dogs 2022 ·Molecular Cancer Therapeutics ·Amy K. LeBlanc, Christina Mazcko, Timothy M. Fan, David M. Vail, (unknown), Jeffrey N. Bryan, (unknown), (unknown), (unknown), Jesse D. Vargas, Jeevan Prasaad Govindharajulu, (unknown), (unknown), Apurva K. Srivastava, Tsui‐Fen Chou, Gordon M. Stott, Joseph M. Covey, Barbara Mroczkowski, James H. Doroshow	6
7	Discovery of Potent Orally Bioavailable WD Repeat Domain 5 (WDR5) Inhibitors Using a Pharmacophore-Based Optimization 2022 ·Journal of Medicinal Chemistry ·(unknown), Kenneth M. Meyers, (unknown), (unknown), Jianhua Tian, Joseph Alvarado, Jiqing Sai, (unknown), (unknown), Tyson A. Rietz, Bin Zhao, William Moore, Gordon M. Stott, William P. Tansey, Taekyu Lee, Stephen W. Fesik	21
8	Structure-based discovery of potent WD repeat domain 5 inhibitors that demonstrate efficacy and safety in preclinical animal models 2022 ·Proceedings of the National Academy of Sciences ·(unknown), Somenath Chowdhury, Kenneth M. Meyers, Jianhua Tian, Jiqing Sai, (unknown), (unknown), John Sensintaffar, Tyson A. Rietz, (unknown), Jing Wang, Brian C. Grieb, Shelly L. Lorey, Gregory C. Howard, Qi Liu, William Moore, Gordon M. Stott, William P. Tansey, Taekyu Lee, Stephen W. Fesik	17
9	Allosteric p97 Inhibitors Can Overcome Resistance to ATP‐Competitive p97 Inhibitors for Potential Anticancer Therapy 2020 ·ChemMedChem ·Feng Wang, Shan Li, (unknown), Gordon M. Stott, Andrew Flint, Tsui‐Fen Chou	27
10	Pharmacodynamics of first-in-class p97 inhibitors that disrupt protein homeostasis in cancer. 2018 ·Journal of Clinical Oncology ·Apurva K. Srivastava, Jeevan Prasaad Govindharajulu, Melinda G. Hollingshead, Howard Stotler, (unknown), Tsui‐Fen Chou, (unknown), (unknown), Gordon M. Stott, James H. Doroshow, Ralph E. Parchment	3
11	Zebrafish as a Model Organism for the Identification and Characterization of Drugs and Genes Affecting p53 Signaling 2002 ·Current Biology ·Ulrike Langheinrich, Elisabeth Hennen, Gordon M. Stott, (unknown)	310

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact